Please login to the form below

Not currently logged in
Email:
Password:

Bayer's Kirstyn Nicholas joins Spirit Healthcare

Takes up role as regional business director

edit-Spirit-Healthcare-Kirstyn-NicholasLeicestershire, UK, based Spirit Healthcare has named Kirstyn Nicholas as regional business director.

Nicholas joins from Bayer, where she was principal territory manager for almost ten years.

The role included working with CCG leads, consultants and clinical scientists and prior to that she worked as healthcare development manager at Bayer HealthCare.

Commenting on her appointment, Nicholas said: “I am thrilled to be working for such a refreshingly innovative company that provides a range of high quality products and solution as well as the internal knowledge, passion and commitment to improve patient lives.”

Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.

Chris Barker, chief executive of Spirit Healthcare, added: “Kirstyn has only been with the company a few weeks and has already made a significant contribution. It is great to have such talent on the team as we continue to expand.”

The expansion follows the successful launch of EMPOWER Structured Diabetes Education and the introduction of TEE2 to its diabetes portfolio.

Spirit Healthcare is a provider of healthcare solution to the NHS and private hospitals, recently winning a PMEA award for Excellence in Healthcare Collaboration and Partnerships Leicester City TotalCare Project.

11th February 2015

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics